Kyowa Kirin Co., Ltd. Download PDF
Market: Tokyo
Symbol: 4151
ISIN: JP3256000005
Sector: Pharmaceutical
Share Graph
Share Data 18/02/2025
Currency JPY
Previous Close 2,058
Change (%) 0.19
Volume 863,300
Number of Shares ( mil) 525.63
Market Cap ( mil) 1,081,492.98
Latest press releases
06/02/2025 Announcement of Consolidated Financial Results Fiscal 2024
06/02/2025 Kyowa Kirin Announces Changes in Directors and AuditorsPDF file
06/02/2025 Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs
20/01/2025 Kyowa Kirin Received Prime Minister’s Award for Japan Medical Research and Development Grand Prize
24/12/2024 Kyowa Kirin Announces Newly Established Chief Digital Transformation Officer (CDXO)PDF file
09/12/2024 Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting
21/11/2024 Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
01/11/2024 Announcement Regarding the Transfer of Sales from Kyowa Kirin to LEO Pharma Following the Termination of the Distribution and Co-Promotion Agreement for the Psoriasis Vulgaris Treatment "Dovobet® Ointment, Gel, and Foam” in Japan
31/10/2024 Notice Regarding Changes of Representative Directors
31/10/2024 Announcement of Consolidated Financial Results Fiscal 2024 Third Quarter
24/10/2024 A Faculty Member of the School of Life Science and Technology, Institute of Science Tokyo has been Appointed as a Researcher at Kyowa Kirin through the Cross-Appointment System.
01/08/2024 Announcement of Consolidated Financial Results Fiscal 2024 Second Quarter

Company presentation
Kyowa Kirin is an R&D-based life sciences company with special strengths in biotechnology. The Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.